Financials
- Market Capitalization 2.94 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.56
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1646 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.12 USD | -1.31% | -1.99% | -14.82% | +93.02% | 3.02 B USD | ||
| 1667 | ELVN Enliven Therapeutics, Inc. - Common Stock | 39.49 USD | -3.31% | -5.64% | -28.20% | +91.14% | 2.89 B USD | ||
| 1678 | RCUS Arcus Biosciences, Inc. Common Stock | 22.81 USD | -6.29% | -6.17% | -7.58% | +39.26% | 2.90 B USD | ||
| 1679 | DYN Dyne Therapeutics, Inc. - Common Stock | 15.41 USD | -3.45% | +1.45% | -16.25% | -34.17% | 2.88 B USD |